Linking metabolite sensing and gene expression in malaria parasites

将疟疾寄生虫的代谢物传感和基因表达联系起来

基本信息

  • 批准号:
    10593642
  • 负责人:
  • 金额:
    $ 19.94万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-11-09 至 2024-10-31
  • 项目状态:
    已结题

项目摘要

Malaria is a life-threatening disease that is transmitted to humans by the bite of Anopheline mosquitoes infected with Plasmodium parasites. Proliferation of parasites within erythrocytes in the bloodstream is central to the parasite’s survival and results in the pathogenesis of malaria. Little is known about how the metabolic environment of the parasite is sensed and linked to changes in gene expression. One of the major factors underlying severe malaria, caused by infection with Plasmodium falciparum, is lactic acidosis, which has a complex etiology, with lactate being produced by both the parasite and the host. During the asexual stages, P. falciparum parasites carry out fermentative glycolysis leading to the conversion of pyruvate into lactate. In addition, the host, due to aerobic glycolysis in proliferating immune cells and anaerobic glycolysis in hypoxic cells, contributes to increased lactate levels in the bloodstream. In vitro studies have shown that the parasite responds to changes in host lactate levels. Lactate accumulation can retard parasite growth, alter the rate of switching to transmissible forms, and has been associated with virulence gene expression. However, the mechanism underlying these profound changes in parasite phenotypes is unknown. In a recent study, a new post-translational modification (PTM), lactylation, was reported in human and mouse cells, that responds to lactate levels. In mammalian cells, several hundred proteins including histones are lactylated, and increased lactate levels in the course of a bacterial infection resulted in gene expression changes in macrophages, providing a link between cellular metabolism and gene expression. We have discovered this new PTM on the tails of multiple histones in P. falciparum. We hypothesize that lactate-derived lactylation of parasite histones is a novel histone code signature that mediates gene expression changes linked to lactate metabolism. We will comprehensively assess histone lactylation dynamics through the parasite asexual cycle as well as the ability of histone lactylation to be altered by perturbations in lactate metabolism. These investigations will be performed both in a diverse panel of laboratory strains, as well as patient isolates with different disease severity. We will also identify the target genes of histone lactylation and their association with transcriptional programs linked to parasite cellular processes. The findings from this proposed work have the potential to establish a critical role for histone lactylation at the fulcrum between lactate metabolism and gene expression in asexual stages of P. falciparum, with significant implications for malaria pathogenesis and transmission.
疟疾是一种威胁生命的疾病,通过受感染的按蚊叮咬传播给人类 疟原虫寄生虫寄生虫在血流中红细胞内的增殖是血液循环的核心。 寄生虫的生存和疟疾的发病机制的结果。人们对新陈代谢是如何 寄生虫的环境被感知并与基因表达的变化相关联。的主要因素之一 由恶性疟原虫感染引起的潜在严重疟疾是乳酸酸中毒, 复杂的病因学,由寄生虫和宿主产生乳酸。在无性繁殖阶段,P. 恶性疟原虫进行发酵糖酵解,导致丙酮酸转化为乳酸。在 此外,宿主由于增殖免疫细胞中的有氧糖酵解和缺氧环境中的无氧糖酵解, 细胞,有助于增加血液中的乳酸水平。体外研究表明, 对宿主乳酸水平的变化做出反应。乳酸积累可以延缓寄生虫的生长,改变寄生虫的生长速率, 转化为可传播的形式,并与毒力基因表达有关。但 寄生虫表型发生这些深刻变化的机制尚不清楚。在最近的一项研究中, 翻译后修饰(PTM),乳酰化,在人类和小鼠细胞中报道, 乳酸水平。在哺乳动物细胞中,包括组蛋白在内的数百种蛋白质被乳酸化, 细菌感染过程中的乳酸水平导致巨噬细胞中的基因表达变化, 提供细胞代谢和基因表达之间的联系。我们已经发现了这个新的PTM上的 恶性疟原虫中多组蛋白的尾部。我们假设寄生虫组蛋白的乳酸衍生的乳酸化是 一种新的组蛋白编码签名,介导与乳酸代谢相关的基因表达变化。我们将 通过寄生虫无性周期全面评估组蛋白乳酸化动力学以及 组蛋白乳酸化被乳酸代谢的扰动改变。这些调查将在 在不同的实验室菌株组以及具有不同疾病严重程度的患者分离株中。我们将 还确定了组蛋白乳酸化的靶基因及其与转录程序的关联, 寄生的细胞过程。这项拟议工作的结果有可能确立一个关键作用, 组蛋白乳酸化是乳酸代谢和基因表达的支点。 恶性疟原虫,对疟疾发病机制和传播具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Manoj T Duraisingh其他文献

Hungry for control: metabolite signaling to chromatin in emPlasmodium falciparum/em
渴望控制:恶性疟原虫中代谢物向染色质的信号传导
  • DOI:
    10.1016/j.mib.2024.102430
  • 发表时间:
    2024-04-01
  • 期刊:
  • 影响因子:
    7.500
  • 作者:
    Ruth Lappalainen;Manish Kumar;Manoj T Duraisingh
  • 通讯作者:
    Manoj T Duraisingh

Manoj T Duraisingh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Manoj T Duraisingh', 18)}}的其他基金

Malaria parasite determinants of host cell tropism
疟疾寄生虫宿主细胞趋向性的决定因素
  • 批准号:
    10646370
  • 财政年份:
    2022
  • 资助金额:
    $ 19.94万
  • 项目类别:
Evaluating host-directed therapeutics against blood-stage malaria parasites
评估针对血期疟疾寄生虫的宿主导向疗法
  • 批准号:
    10665779
  • 财政年份:
    2022
  • 资助金额:
    $ 19.94万
  • 项目类别:
Evaluating host-directed therapeutics against blood-stage malaria parasites
评估针对血期疟疾寄生虫的宿主导向疗法
  • 批准号:
    10528133
  • 财政年份:
    2022
  • 资助金额:
    $ 19.94万
  • 项目类别:
Malaria parasite determinants of host cell tropism
疟疾寄生虫宿主细胞趋向性的决定因素
  • 批准号:
    10522253
  • 财政年份:
    2022
  • 资助金额:
    $ 19.94万
  • 项目类别:
Molecular basis of antimalarial drug resistance in Plasmodium vivax
间日疟原虫抗疟药物耐药性的分子基础
  • 批准号:
    10593992
  • 财政年份:
    2022
  • 资助金额:
    $ 19.94万
  • 项目类别:
Developing a barcoded malaria parasite panel to assess broadly neutralizing antibodies
开发带条形码的疟原虫面板来评估广泛中和抗体
  • 批准号:
    10655645
  • 财政年份:
    2022
  • 资助金额:
    $ 19.94万
  • 项目类别:
Comparative systems biology of apicomplexan cell division
顶端复合体细胞分裂的比较系统生物学
  • 批准号:
    10539938
  • 财政年份:
    2022
  • 资助金额:
    $ 19.94万
  • 项目类别:
Developing a barcoded malaria parasite panel to assess broadly neutralizing antibodies
开发带条形码的疟原虫面板来评估广泛中和抗体
  • 批准号:
    10511052
  • 财政年份:
    2022
  • 资助金额:
    $ 19.94万
  • 项目类别:
Comparative systems biology of apicomplexan cell division
顶端复合体细胞分裂的比较系统生物学
  • 批准号:
    10669790
  • 财政年份:
    2022
  • 资助金额:
    $ 19.94万
  • 项目类别:
Developing comparative chemical genomics and genetic validation tools for Babesia spp.
开发巴贝虫属的比较化学基因组学和遗传验证工具。
  • 批准号:
    10042448
  • 财政年份:
    2020
  • 资助金额:
    $ 19.94万
  • 项目类别:

相似海外基金

New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
  • 批准号:
    10649771
  • 财政年份:
    2023
  • 资助金额:
    $ 19.94万
  • 项目类别:
Derivation and validation of a clinical prediction rule to identify febrile infants 61 to 90 days old at low and non-negligible risk of invasive bacterial infections
推导和验证临床预测规则,以识别 61 至 90 天大的发热婴儿,其侵袭性细菌感染的风险较低且不可忽略
  • 批准号:
    10574286
  • 财政年份:
    2023
  • 资助金额:
    $ 19.94万
  • 项目类别:
Structural and functional studies of YbtPQ for fighting bacterial infections
YbtPQ 对抗细菌感染的结构和功能研究
  • 批准号:
    10644889
  • 财政年份:
    2023
  • 资助金额:
    $ 19.94万
  • 项目类别:
A gut feeling: How can gastrointestinal bacterial infections alter female reproductive tract immunity and control of sexually transmitted infections
直觉:胃肠道细菌感染如何改变女性生殖道免疫力和性传播感染的控制
  • 批准号:
    MR/X031993/1
  • 财政年份:
    2023
  • 资助金额:
    $ 19.94万
  • 项目类别:
    Research Grant
Molecular probes to diagnose pathoadapatations in bacterial infections
诊断细菌感染病理适应的分子探针
  • 批准号:
    EP/X014479/1
  • 财政年份:
    2023
  • 资助金额:
    $ 19.94万
  • 项目类别:
    Research Grant
Using Small Area Variation Analysis to Investigate Sources of Practice Variation for Febrile Infants at Risk for Invasive Bacterial Infections
使用小面积变异分析来调查有侵袭性细菌感染风险的发热婴儿的实践变异来源
  • 批准号:
    10588846
  • 财政年份:
    2023
  • 资助金额:
    $ 19.94万
  • 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
  • 批准号:
    10674221
  • 财政年份:
    2023
  • 资助金额:
    $ 19.94万
  • 项目类别:
SimCell vaccines against Staphylococcus aureus bacterial infections
针对金黄色葡萄球菌细菌感染的 SimCell 疫苗
  • 批准号:
    10073241
  • 财政年份:
    2023
  • 资助金额:
    $ 19.94万
  • 项目类别:
    Grant for R&D
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
  • 批准号:
    2306943
  • 财政年份:
    2023
  • 资助金额:
    $ 19.94万
  • 项目类别:
    Standard Grant
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 19.94万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了